Produktbild: Neuroimmune Circuits, Drugs of Abuse, and Infectious Diseases
Band 493

Neuroimmune Circuits, Drugs of Abuse, and Infectious Diseases

Fr. 192.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

23.03.2013

Herausgeber

Herman Friedman + weitere

Verlag

Springer Us

Seitenzahl

274

Maße (L/B/H)

25.4/17.8/1.6 cm

Gewicht

547 g

Auflage

Softcover reprint of the original 1st ed. 2001

Sprache

Englisch

ISBN

978-1-4757-8686-6

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

23.03.2013

Herausgeber

Verlag

Springer Us

Seitenzahl

274

Maße (L/B/H)

25.4/17.8/1.6 cm

Gewicht

547 g

Auflage

Softcover reprint of the original 1st ed. 2001

Sprache

Englisch

ISBN

978-1-4757-8686-6

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Neuroimmune Circuits, Drugs of Abuse, and Infectious Diseases
  • Preface: Introduction and Perspectives; H. Friedman, T.W. Klein, J. Madden. 1. Targeting the Brain's Immune System: A Psychopharmacological Approach to Central Nervous System Infection; P.K. Peterson, et al. 2. Model Systems for Assessing Cognitive Function: Implications for HIV-1 Infection and Drugs of Abuse; W.E. Zink, et al. 3. Direct and Indirect Mechanisms of HIV-1 Neuropathogenesis in the Human Central Nervous System; J. Hou, E.O. Major. 4. Chemokine Receptors on Brain Endothelia - Keys to HIV-1 Infection and Drugs of Abuse? M. Fiala, et al. 5. Neurotropic Factor Regulation of Human Immunodeficiency Virus Type 1 Replication in Human Blood Derived Macrophages Through Modulation of Coreceptor Expression; S.M. Harrold, et al. 6. Direct vs. Indirect Modulation of Complex in vitro Human Retroviral Infections by Morphine; S.B. Nyland, et al. 7. Genetic Factors Involved in Central Nervous System/Immune Interactions; R.L. Wilder, et al. 8. Interactions of Opioid Receptors, Chemokines and Chemokine Receptors; I. Szabo, et al. 9. Crosstalk between Chemokine and Opioid Receptors Results in Down-modulation of Cell Migration; I. Szabo, T.J. Rogers. 10. Morphine Upregulates Kappa-Opioid Receptors of Human Lymphocytes; S. Suzuki, et al. 11. Effects of Morphine on T-Cell Recirculation in Rhesus Monkeys; R.M. Donahoe, et al. 12. Mitogen Induced Activation of Mouse T Cells Increases Kappa Opioid Receptor Expression; J.M. Bidlack, M.K. Abraham. 13. Self Enhancement of Phagocytosis by Murine Resident Peritoneal Macrophages and its Relationshipto Morphine Effects on the Process; W.E. Pagan, et al. 14. Role of Mu-Opioid Receptor in Immune Function; S. Roy, et al. 15. Opiates Promote T Cell Apoptosis Through JNK and Caspase Pathway; P. Singhal, et al. 16. Role of Beta-Endorphin in the Modulation of Immune Responses: Perspectives in Autoimmune Diseases; P. Sacerdote, et al. 17. Modulation of FAS/FASL in a Murine Retroviral Infection by AZT and Methionine Enkephalin; R. Bowden, et al. 18. Acute Effects of Heroin on the Cellularity of the Spleen and the Apoptosis of Splenic Leukocytes; K. Fecho, D.T. Lysle. 19. Alteration of Early T Cell Development by Opioid and Superantigen Stimulation; L.E. McCarthy, T.J. Rogers. 20. Effect of Opioids on Oral Salmonella Infection and Immune Function; T.K. Eisenstein, et al. 21. Altered T-Cell Responsiveness in Morphine `Tolerant' Rats: Evidence for a Potential Role of the Paraventricular Nucleus of the Hypothalamus; R.D. Mellon, et al. 22. Actions of Endotoxin and Morphine; S. Chang, et al. 23. Pharmaconeuroimmunology in the Intestinal Tract: Opioid and Cannabinoid Receptors, Enteric Neurons and Mucosal Defense; D.R. Brown, et al. 24. Cannabinoid-Mediated Inhibition of Inducible Nitric Oxide Production by Rat Microglial Cells: Evidence for CB1 Receptor Participation; G.A. Cabral, et al. 25. Modulation of CB1 mRNA Upon Activation of Murine Splenocytes; S.N. Noe, et al. 26. Downregulation of Cannabinoid Receptor 2 (CB2) Messenger RNA Expression During in vitro Stimulation of Murine Splenocytes with Lipopolysaccharide; Sumi Fong Lee, et al. 27. CB1 and CB2 Receptor mR